跳至主要内容
临床试验/EUCTR2009-017039-16-CZ
EUCTR2009-017039-16-CZ进行中(未招募)不适用

Effect of strontium ranelate (2g per day) in the management of long bone fractures with delayed-union or non union: an international open label study

Institut de Recherches Internationales Servier0 个研究点目标入组 40 人开始时间: 2010年3月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men aged 18 years and postmenopausal women with a fracture of the limb or clavicle with delayed union, defined as an absence of radiological full union after 6 months according to investigator’s opinion OR
  • with Non-union defined as non-union for at least 6 months and no sign of radiological healing or bone reaction since at least 3 months,
  • Ambulatory prior to the qualifying fracture.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 27
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 13

排除标准

  • ­Not pathological fracture,
  • Bone-related disease other than osteoporosis,
  • Septic or synovial or congenital pseudarthrosis,
  • Fracture with a fracture gap, after reduction or treatment, greater than more the half the width of the affected bone,
  • Concomitant treatments interfering with bone metabolism,
  • History of venous thrombo-embolism,
  • History of intolerance, allergy or hypersensitivity to strontium ranelate,
  • Contraindication to Calperos D3.

研究者

相似试验

进行中(未招募)
不适用
Effect of strontium ranelate in the management of long bone fractures.Delayed and non-united fracturesMedDRA version: 14.1Level: PTClassification code 10017088Term: Fracture nonunionSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 14.1Level: PTClassification code 10017081Term: Fracture delayed unionSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2009-017039-16-HUInstitut de Recherches Internationales Servier40
进行中(未招募)
不适用
Effect of strontium ranelate in the management of long bone fracturesDelayed and non-united fracturesMedDRA version: 14.0Level: PTClassification code 10017081Term: Fracture delayed unionSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 14.0Level: PTClassification code 10017088Term: Fracture nonunionSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2009-017039-16-DEInstitut de Recherches Internationales Servier40
进行中(未招募)
不适用
Effect of strontium ranelate (2g per day) in the management of lower limb fractures with delayed-union or non union: an international open label study in patients with osteoporosis - ND
EUCTR2009-017039-16-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER40
进行中(未招募)
1 期
Effect of strontium ranelate (2g per day) in the management of lower limb fractures with delayed-union or non union: an international open label study in patients with osteoporosisDelayed and non-united fractures in osteoporotic patientsMedDRA version: 12.1Level: LLTClassification code 10031283Term: Osteoporosis fracture
EUCTR2009-017039-16-FRInstitut de Recherches Internationales Servier40
进行中(未招募)
不适用
The efficacy and safety of 2g strontium ranelate in the treatment of male osteoporosis.A prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 year. - MALEOmale osteoporosisMedDRA version: 9.1Level: PTClassification code 10031282Term: Osteoporosis
EUCTR2006-006086-16-BEInstitut de Recherches Internationales Servier221